{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:01:04Z","timestamp":1793037664970,"version":"4.5.0"},"reference-count":66,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>The neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), and lymphocyte-to-monocyte ratio (LMR) are peripheral serum markers commonly utilized as cost-effective indicators of inflammation. However, their efficacy as predictors of clinical disease activity in inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn\u2019s disease (CD), remains uncertain. To address this ambiguity, we conducted a meta-analysis to evaluate the clinical significance of NLR, PLR, and LMR in patients with IBD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A comprehensive search was conducted in the PubMed, Embase, Web of Science, and Cochrane databases, with the last search date being October 2024. Baseline values of NLR, PLR, and LMR during active and remission phases, as well as moderate and severe conditions, were analyzed as primary endpoints in patients with IBD compared to healthy populations, using risk ratios (WMD) and corresponding 95% confidence interval (CI) estimates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Twenty-three cohort studies involving 3550 IBD patients and 1010 healthy people were finally included in this meta-analysis. The results of the meta-analysis showed that peripheral serum NLR and PLR were significantly higher in IBD patients than in the healthy population NLR [WMD=1.57,95%CI(1.14,2.01),P&amp;lt;0.001], PLR [WMD=60.66,95%CI(51.68,69.64),P&amp;lt;0.001]; NLR in active versus remission stage of IBD, PLR, LMR had significant differences NLR [WMD=1.50,95%CI(1.23,1.78),P&amp;lt;0.001], PLR [WMD=69.02,95%CI(39.66,98.39,P&amp;lt;0.001], LMR [WMD=-1.14,95%CI(-1.43,-0.86,P&amp;lt;0.001]; IBD active period and remission period NLR, PLR and LMR had significant differences. 0.001]; there were significant differences in NLR and PLR between moderate and severe IBD NLR [WMD=-1.41,95%CI(-2.13,-0.69),P&amp;lt;0.001], PLR [WMD=-112.03,95%CI(-143.87,-80.19),P&amp;lt;0.001]; the diagnostic accuracy of markers in predicting the clinical activity of IBD was relatively good. The diagnostic accuracy of markers in predicting IBD clinical activity was more favorable AUC [ES=0.72,95%CI(0.69,0.75),P&amp;lt;0.001].<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In patients with IBD, elevated NLR and PLR are associated with increased disease activity and severity in UC and CD. Conversely, an elevated LMR is linked to reduced disease activity in IBD. Based on diagnostic accuracy results, inflammatory markers NLR and PLR serve as effective biomarkers for assessing IBD activity, thereby providing valuable insights for treatment decisions in IBD patients. However, LMR may not be a reliable independent marker due to conflicting or non-significant results. We anticipate that further high-quality prospective studies will validate our findings in the future.<\/jats:p><\/jats:sec><jats:sec><jats:title>Systematic review registration<\/jats:title><jats:p><jats:uri>https:\/\/www.crd.york.ac.uk\/PROSPERO\/<\/jats:uri>, identifier CRD42024608118.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fimmu.2025.1623899","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T05:26:14Z","timestamp":1753421174000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["The predictive role of peripheral serum inflammatory markers NLR, PLR, and LMR in ulcerative colitis and Crohn\u2019s disease: a systematic review and meta-analysis"],"prefix":"10.3389","volume":"16","author":[{"given":"Shufa","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhong","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/s41575-022-00593-y","article-title":"Multiomics to elucidate inflammatory bowel disease risk factors and pathways","volume":"19","author":"Agrawal","year":"2022","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.14309\/ajg.0000000000002187","article-title":"Has the incidence of inflammatory bowel disease peaked? Evidence from the population-based NorDIBD cohort 1978-2020","volume":"118","author":"Larsen","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2018","journal-title":"Lancet"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1298186","article-title":"Emerging strategy towards mucosal healing in inflammatory bowel disease: what the future holds","volume":"14","author":"Wang","year":"2023","journal-title":"Front Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1136\/bmjgast-2019-000361","article-title":"Risk of colorectal cancer in a population-based study 20 years after diagnosis of ulcerative colitis: results from the IBSEN study","volume":"7","author":"Klepp","year":"2020","journal-title":"BMJ Open Gastroenterol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/gou031","article-title":"Histological evaluation in ulcerative colitis","volume":"2","author":"DeRoche","year":"2014","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1023\/b:ddas.0000020506.84248.f9","article-title":"IBS-like symptoms in patients with inflammatory bowel disease in remission; relationships with quality of life and coping behavior","volume":"49","author":"Minderhoud","year":"2004","journal-title":"Dig Dis Sci"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2021.2022193","article-title":"Monitoring of intestinal inflammation and prediction of recurrence in ulcerative colitis","volume":"57","author":"Ge","year":"2022","journal-title":"Scand J Gastroenterol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/ped.13892","article-title":"Laboratory values in Japanese children with newly diagnosed inflammatory bowel disease","volume":"61","author":"Takaki","year":"2019","journal-title":"Pediatr Int"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1053\/j.gastro.2010.11.058","article-title":"The utility of biomarkers in the diagnosis and therapy of inflammatory bowel disease","volume":"140","author":"Lewis","year":"2011","journal-title":"Gastroenterology"},{"key":"B11","doi-asserted-by":"publisher","first-page":"299","DOI":"10.15403\/jgld.2014.1121.273.pti","article-title":"Fecal calprotectin in assess ing inflammatory bowel disease endoscopic activity: a diagnostic accu racy meta-analysis","volume":"27","author":"Rokkas","year":"2018","journal-title":"J Gastrointestin Liver Dis"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S452444","article-title":"Neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and monocyte-to-lymphocyte ratio (MLR) as biomarkers in diagnosis evaluation of acute exacerbation of chronic obstructive pulmonary disease: A retrospective, observational study","volume":"19","author":"Cai","year":"2024","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.44842","article-title":"Significance of the neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio, and preoperative nutritional index as predictors of morbidity in patients who underwent liver resection for alveolar echinococcosis","volume":"15","author":"Kartal","year":"2023","journal-title":"Cureus"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1309835","article-title":"The neutrophil-lymphocyte ratio predicts all-cause and cardiovascular mortality among U.S. adults with rheumatoid arthritis: results from NHANES 1999-2020","volume":"14","author":"Zhou","year":"2023","journal-title":"Front Immunol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"399","DOI":"10.4103\/ijmr.IJMR_1234_17","article-title":"Association between neutrophil-lymphocyte & platelet lymphocyte ratios with prognosis & mortality in rapidly progressive glomerulonephritis","volume":"150","author":"Toraman","year":"2019","journal-title":"Indian J Med Res"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2012.06.004","article-title":"Assessment of neutrophil-lymphocyte ratio in ulcerative colitis: a promising marker in predicting disease severity","volume":"36","author":"Torun","year":"2012","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/MIB.0000000000000427","article-title":"Monocytosis and a low lymphocyte to monocyte ratio are effective biomarkers of ulcerative colitis disease activity","volume":"21","author":"Cherfane","year":"2015","journal-title":"Inflammation Bowel Dis"},{"key":"B18","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/S0140-6736(23)00821-8","article-title":"Cutaneous melanoma","volume":"402","author":"Long","year":"2023","journal-title":"Lancet"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S446723","article-title":"Predictive value of MHR and NLR for ulcerative colitis disease activity","volume":"17","author":"Liu","year":"2024","journal-title":"Int J Gen Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines12051119","article-title":"Remission factors for ustekinumab treatment of ulcerative colitis: A multicenter retrospective study of real-world data in Japan","volume":"12","author":"Omori","year":"2024","journal-title":"Biomedicines"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-022-07547-z","article-title":"Neutrophil-to-lymphocyte ratio: an easy marker for the diagnosis and monitoring of inflammatory bowel disease in children","volume":"68","author":"\u015eim\u015fek-Onat","year":"2023","journal-title":"Dig Dis Sci"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0280252","article-title":"Neutrophil-to-lymphocyte ratio may predict clinical relapse in ulcerative colitis patients with mucosal healing","volume":"18","author":"Kurimoto","year":"2023","journal-title":"PloS One"},{"key":"B23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1186\/s12876-022-02571-9","article-title":"Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as potential markers for ulcerative colitis: a retrospective study","volume":"22","author":"Feng","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1186\/s12876-022-02634-x","article-title":"Common laboratory blood test immune panel markers are useful for grading ulcerative colitis endoscopic severity","volume":"22","author":"Cui","year":"2022","journal-title":"BMC Gastroenterol"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.19942","article-title":"Prediction of mucosal health by NLR, CRP x NLR and MPV in ulcerative colitis: can their availability change according to treatment options","volume":"13","author":"Cifci","year":"2021","journal-title":"Cureus"},{"key":"B26","doi-asserted-by":"publisher","first-page":"62","DOI":"10.5217\/ir.2019.09156","article-title":"The role of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio in ulcerative colitis","volume":"19","author":"Jeong","year":"2021","journal-title":"Intest Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1159\/000520523","article-title":"Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios as noninvasive predictors of the therapeutic outcomes of systemic corticosteroid therapy in ulcerative colitis","volume":"6","author":"Endo","year":"2021","journal-title":"Inflammation Intest Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169845","article-title":"Neutrophil-to-lymphocyte ratio for predicting loss of response to infliximab in ulcerative colitis","volume":"12","author":"Nishida","year":"2017","journal-title":"PloS One"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1186\/s13317-019-0114-8","article-title":"Neutrophil\/lymphocyte ratio and lymphocyte\/monocyte ratio in ulcerative colitis as non-invasive biomarkers of disease activity and severity","volume":"10","author":"Okba","year":"2019","journal-title":"Auto Immun Highlights"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1515\/jomb-2017-0050","article-title":"Platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio predict mucosal disease severity in ulcerative colitis","volume":"37","author":"Akpinar","year":"2018","journal-title":"J Med Biochem"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.kjms.2015.10.001","article-title":"The relationship between the neutrophil-lymphocyte ratio and disease activity in patients with ulcerative colitis","volume":"31","author":"Demir","year":"2015","journal-title":"Kaohsiung J Med Sci"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-014-0683-5","article-title":"Does neutrophil-to-lymphocyte ratio predict active ulcerative colitis","volume":"127","author":"Posul","year":"2015","journal-title":"Wien Klin Wochenschr"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.21564","article-title":"Neutrophil-lymphocyte ratio as a predictor of disease severity in ulcerative colitis","volume":"27","author":"Celikbilek","year":"2013","journal-title":"J Clin Lab Anal"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/3467419","article-title":"The relationship between C-reactive protein\/albumin ratio and disease activity in patients with inflammatory bowel disease","volume":"2020","author":"Chen","year":"2020","journal-title":"Gastroenterol Res Pract"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1155\/2019\/6517549","article-title":"Correlation between serological biomarkers and disease activity in patients with inflammatory bowel disease","volume":"2019","author":"Xu","year":"2019","journal-title":"BioMed Res Int"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/3526460","article-title":"Diagnostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in Crohn\u2019s disease","volume":"2017","author":"Feng","year":"2017","journal-title":"Gastroenterol Res Pract"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.12998\/wjcc.v9.i2.334","article-title":"Effective immune-inflammation index for ulcerative colitis and activity assessments","volume":"9","author":"Zhang","year":"2021","journal-title":"World J Clin Cases"},{"key":"B38","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1159\/000490795","article-title":"A simple noninvasive score predicts disease activity and deep remission in ulcerative colitis","volume":"3","author":"Hanafy","year":"2018","journal-title":"Inflammation Intest Dis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4149\/bll_2015_041","article-title":"Neutrophil-to-lymphocyte ratio in inflammatory bowel disease - as a new predictor of disease severity","volume":"116","author":"Acarturk","year":"2015","journal-title":"Bratisl Lek Listy"},{"key":"B40","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1053\/j.gastro.2009.09.056","article-title":"Belgian Inflammatory Bowel Disease Research Group; North-Holland Gut Club. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn\u2019s disease","volume":"138","author":"Baert","year":"2010","journal-title":"Gastroenterology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1111\/apt.13475","article-title":"Systematic review with meta-analysis: mucosal healing is associated with improved long-term outcomes in Crohn\u2019s disease","volume":"43","author":"Shah","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2005.069476","article-title":"Laboratory markers in IBD: useful, magic, or unnecessary toys","volume":"55","author":"Vermeire","year":"2006","journal-title":"Gut"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2362.1982.tb02244.x","article-title":"Serum levels of C-reactive protein in Crohn\u2019s disease and ulcerative colitis","volume":"12","author":"Fagan","year":"1982","journal-title":"Eur J Clin Invest"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c3369","article-title":"Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis","volume":"341","author":"van Rheenen","year":"2010","journal-title":"BMJ"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.62347\/LXBG8588","article-title":"Predictive value of serum markers for mucosal healing in patients with inflammatory bowel disease","volume":"16","author":"Lei","year":"2024","journal-title":"Am J Transl Res"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11020400","article-title":"The role of in nate and adaptive immune cells in the pathogenesis and de velopment of the inflammatory response in ulcerative colitis","volume":"11","author":"Kaluz na","year":"2022","journal-title":"J Clin Med"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/ecco-jcc\/jjy215","article-title":"Neutrophil extracellular traps sustain inflammatory signals in ulcerative colitis","volume":"13","author":"Dinallo","year":"2019","journal-title":"J\u00a0Crohns Colitis"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1701643","article-title":"REDD1\/autophagy pathway is associated with neutrophil-driven IL-1\u03b2 inflammatory response in active ulcerative colitis","volume":"200","author":"Angelidou","year":"2018","journal-title":"J Immunol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v29.i18.2733","article-title":"Study of tumor necrosis factor receptor in the inflammatory bowel disease","volume":"29","author":"Souza","year":"2023","journal-title":"World J Gastroenterol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1002\/iid3.1224","article-title":"Investigating the association between the tissue expression of miRNA-101, JAK2\/STAT3 with TNF-\u03b1, IL-6, IL-1\u03b2, and IL-10 cytokines in the ulcerative colitis patients","volume":"12","author":"Voshagh","year":"2024","journal-title":"Immun Inflammation Dis"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2018.03.006","article-title":"HLA-G is expressed in intestinal samples of ulcerative colitis and Crohn\u2019s disease patients and HLA-G5 expression is differentially correlated with TNF and IL-10 cytokine expression","volume":"79","author":"Gomes","year":"2018","journal-title":"Hum Immunol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/eji.202048622","article-title":"Fc\u03b3RI plays a critical role in patients with ulcerative colitis relapse","volume":"51","author":"Li","year":"2021","journal-title":"Eur J Immunol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20010057","article-title":"NLRP3-dependent and-independent processing of interleukin (IL)-1\u03b2 in active ulcerative colitis","volume":"20","author":"Ranson","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines8080275","article-title":"Neutrophil extracellular traps impair intestinal barrier function during experimental colitis","volume":"8","author":"Lin","year":"2020","journal-title":"Biomedicines"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/00365521.2016.1235224","article-title":"Neutrophils in ulcerative colitis: a review of selected biomarkers and their potential therapeutic implications","volume":"52","author":"Muthas","year":"2017","journal-title":"Scand J Gastroenterol"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-024-02642-9","article-title":"The relationship between extreme inter-individual variation in macrophage gene expression and genetic susceptibility to inflammatory bowel disease","volume":"143","author":"O\u2019Brien","year":"2024","journal-title":"Hum Genet"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.4081\/ejh.2024.4101","article-title":"Deubiquitinase USP14 is upregulated in Crohn\u2019s disease and inhibits the NOD2 pathway mediated inflammatory response in vitro","volume":"68","author":"Li","year":"2024","journal-title":"Eur J Histochem"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.3390\/cimb45070350","article-title":"Inflammation, autoinflammation and autoimmunity in inflammatory bowel diseases","volume":"45","author":"Padoan","year":"2023","journal-title":"Curr Issues Mol Biol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1186\/s13287-022-03118-1","article-title":"Human umbilical cord-derived mesenchymal stem cells ameliorate experimental colitis by normalizing the gut microbiota","volume":"13","author":"Yang","year":"2022","journal-title":"Stem Cell Res Ther"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.4254\/wjh.v9.i23.979","article-title":"Innate lymphoid cells in tissue homeostasis and diseases","volume":"9","author":"Ignacio","year":"2017","journal-title":"World J Hepatol"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2020.02.016","article-title":"Innate lymphoid cell-epithelial cell modules sustain intestinal homeostasis","volume":"52","author":"Diefenbach","year":"2020","journal-title":"Immunity"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1250982","article-title":"A role for platelets in metabolic reprogramming of tumor-associated macrophages","volume":"14","author":"Kang","year":"2023","journal-title":"Front Physiol"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aao3089","article-title":"Platelet microparticles sustain autophagy-associated activation of neutrophils in systemic sclerosis","volume":"10","author":"Maugeri","year":"2018","journal-title":"Sci Transl Med"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.02.047","article-title":"Regulation of homeostasis and inflammation in the intestine","volume":"140","author":"MacDonald","year":"2011","journal-title":"Gastroenterology"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2021.1935857","article-title":"Blood-based prognostic biomarkers in Crohn\u2019s Disease patients on biologics: a promising tool to predict endoscopic outcomes","volume":"21","author":"Crispino","year":"2021","journal-title":"Expert Opin Biol Ther"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1093\/ibd\/izaa062","article-title":"Novel prognostic biomarkers of mucosal healing in ulcerative colitis patients treated with anti-TNF: neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio","volume":"26","author":"Bertani","year":"2020","journal-title":"Inflammation Bowel Dis"}],"updated-by":[{"DOI":"10.3389\/fimmu.2025.1676750","type":"corrigendum","label":"Corrigendum","source":"publisher","updated":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:00:00Z","timestamp":1755043200000}}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1623899\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T09:11:03Z","timestamp":1755076263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1623899\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":66,"alternative-id":["10.3389\/fimmu.2025.1623899"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1623899","relation":{"corrigendum":[{"id-type":"doi","id":"10.3389\/fimmu.2025.1676750","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"article-number":"1623899"}}